Unternehmen Cocrystal Pharma Inc OTC Bulletin Board
Aktien
US19188J1025
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Sam Lee
CEO | Chief Executive Officer | 64 | 02.01.14 |
James Martin
CEO | Chief Executive Officer | 58 | 23.02.17 |
Roger Kornberg
CHM | Chairman | 77 | 02.01.14 |
Luz Pascual
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Phillip Frost
BRD | Director/Board Member | 87 | 02.01.14 |
Director/Board Member | 68 | 27.05.21 | |
Steven Rubin
BRD | Director/Board Member | 63 | 02.01.14 |
Fred Hassan
BRD | Director/Board Member | 78 | 20.04.23 |
Anthony Japour
BRD | Director/Board Member | 64 | 04.04.19 |
Roger Kornberg
CHM | Chairman | 77 | 02.01.14 |
Sam Lee
CEO | Chief Executive Officer | 64 | 02.01.14 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 10 173 790 | 7 118 978 ( 69,97 %) | 0 | 69,97 % |
Unternehmenskontakt
Cocrystal Pharma, Inc.
19805 North Creek Parkway
98011, Bothell
+877 262 7123
http://www.cocrystalpharma.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+9.42% | 114 Mrd. | |
+11.84% | 104 Mrd. | |
-14.15% | 22.41 Mrd. | |
-1.05% | 22.28 Mrd. | |
-5.29% | 19.07 Mrd. | |
-38.29% | 18 Mrd. | |
-4.16% | 17.89 Mrd. | |
+7.99% | 14.28 Mrd. | |
+36.24% | 12.55 Mrd. |